← Oncology Approval Tracker

FDA DECISION ·

Abiraterone acetate (Yonsa first generic)

abiraterone acetate · Teva Pharmaceuticals USA

First generic approvalFirst genericProstate cancer
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

The first generic of Yonsa 125 mg tablets for metastatic castration-resistant prostate cancer in combination with methylprednisolone.

LAMPGEN ANALYSIS

Why it matters

This generic approval is tied to the Yonsa reference product and its corticosteroid partner.

What research teams should watch

Reconcile the reference formulation, dose and steroid partner before dispensing.

PRIMARY RECORDS

Sources